Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples